Biogen making $7B-plus pharma acquisition
Biogen, which has a significant presence in Research Triangle Park, is spending more than $7 billion to buy Texas-based Reata Pharmaceuticals and bolster its rare disease treatment…
Biogen, which has a significant presence in Research Triangle Park, is spending more than $7 billion to buy Texas-based Reata Pharmaceuticals and bolster its rare disease treatment…